James Quigley
Stock Analyst at Goldman Sachs
(0.21)
# 4,513
Out of 4,659 analysts
335
Total ratings
41.3%
Success rate
-7%
Average return
Main Sectors:
Stocks Rated by James Quigley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVO Novo Nordisk | Maintained: Hold | $47 → $44 | $45.71 | -3.74% | 10 | Aug 6, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 305.00 → kr 285.00 | kr 292.26 | -2.48% | 36 | Aug 6, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €62.50 → €63.50 | €48.74 | +30.28% | 61 | Aug 5, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Hold | €229.00 → €190.00 | €228.90 | -16.99% | 31 | Jul 24, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 670.00 → CHF 680.00 | CHF 565.80 | +20.18% | 22 | Jul 23, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Sell | CHF 111.00 → CHF 113.00 | CHF 125.56 | -10.00% | 27 | Jul 22, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €89.00 → €84.00 | €77.67 | +8.15% | 10 | Jul 6, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 346.00 → CHF 348.00 | CHF 360.90 | -3.57% | 26 | Jun 30, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €214.00 | €180.50 | +18.56% | 23 | Apr 23, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €153.00 → €147.00 | €136.75 | +7.50% | 43 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $55.53 | - | 1 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $121 → $118 | $154.55 | -23.65% | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $892.50 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $60 | $44.97 | n/a | 2 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 15,200p | 11,806p | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €13.00 → €10.50 | €0.96 | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €27.00 → €28.00 | €3.32 | n/a | 10 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 65.00 → CHF 64.00 | CHF 74.85 | n/a | 2 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 38.00 → CHF 21.00 | CHF 44.00 | n/a | 5 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €38.00 → €36.00 | €23.82 | n/a | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $1.91 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €410.00 → €545.00 | €865.60 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | kr 1,950 → kr 2,235 | kr 2,120 | n/a | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $140 → $205 | $27.99 | n/a | 2 | Jan 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $32.96 | n/a | 1 | Jun 20, 2018 |
Novo Nordisk
Aug 6, 2026
Maintained: Hold
Price Target: $47 → $44
Current: $45.71
Upside: -3.74%
Novo Nordisk A/S
Aug 6, 2026
Maintained: Hold
Price Target: kr 305.00 → kr 285.00
Current: kr 292.26
Upside: -2.48%
Bayer Aktiengesellschaft
Aug 5, 2026
Maintained: Buy
Price Target: €62.50 → €63.50
Current: €48.74
Upside: +30.28%
Sartorius Aktiengesellschaft
Jul 24, 2026
Maintained: Hold
Price Target: €229.00 → €190.00
Current: €228.90
Upside: -16.99%
Lonza Group AG
Jul 23, 2026
Maintained: Buy
Price Target: CHF 670.00 → CHF 680.00
Current: CHF 565.80
Upside: +20.18%
Novartis AG
Jul 22, 2026
Maintained: Sell
Price Target: CHF 111.00 → CHF 113.00
Current: CHF 125.56
Upside: -10.00%
Sanofi
Jul 6, 2026
Maintained: Hold
Price Target: €89.00 → €84.00
Current: €77.67
Upside: +8.15%
Roche Holding AG
Jun 30, 2026
Maintained: Hold
Price Target: CHF 346.00 → CHF 348.00
Current: CHF 360.90
Upside: -3.57%
Sartorius Stedim Biotech S.A.
Apr 23, 2026
Maintained: Buy
Price Target: €214.00
Current: €180.50
Upside: +18.56%
Merck KGaA
Apr 16, 2026
Maintained: Buy
Price Target: €153.00 → €147.00
Current: €136.75
Upside: +7.50%
Jan 15, 2026
Upgraded: Hold
Price Target: n/a
Current: $55.53
Upside: -
Sep 12, 2025
Downgraded: Sell
Price Target: $121 → $118
Current: $154.55
Upside: -23.65%
Jul 30, 2025
Maintained: Hold
Price Target: n/a
Current: $892.50
Upside: n/a
Jul 3, 2025
Maintained: Hold
Price Target: $65 → $60
Current: $44.97
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: 15,200p
Current: 11,806p
Upside: n/a
Oct 10, 2023
Maintained: Hold
Price Target: €13.00 → €10.50
Current: €0.96
Upside: n/a
Sep 25, 2023
Maintained: Buy
Price Target: €27.00 → €28.00
Current: €3.32
Upside: n/a
Sep 25, 2023
Maintained: Sell
Price Target: CHF 65.00 → CHF 64.00
Current: CHF 74.85
Upside: n/a
Sep 25, 2023
Maintained: Hold
Price Target: CHF 38.00 → CHF 21.00
Current: CHF 44.00
Upside: n/a
Sep 5, 2023
Maintained: Hold
Price Target: €38.00 → €36.00
Current: €23.82
Upside: n/a
Aug 8, 2023
Maintained: Buy
Price Target: $16 → $15
Current: $1.91
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: €410.00 → €545.00
Current: €865.60
Upside: n/a
May 12, 2023
Initiated Coverage: Sell
Price Target: kr 1,950 → kr 2,235
Current: kr 2,120
Upside: n/a
Jan 5, 2020
Downgraded: Hold
Price Target: $140 → $205
Current: $27.99
Upside: n/a
Jun 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $32.96
Upside: n/a